Profil
Phillip Zamore is the founder of Alnylam Pharmaceuticals, Inc., founded in 2002.
Dr. Zamore is the founder of Voyager Therapeutics, Inc., founded in 2013.
Dr. Zamore currently holds the position of Chairman at RNA Therapeutics Institute.
Dr. Zamore currently holds the position of Professor at UMass Chan Medical School.
Dr. Zamore completed undergraduate and doctorate degrees at Harvard University.
Aktiva positioner av Phillip Zamore
| Företag | Position | Start |
|---|---|---|
UMass Chan Medical School
UMass Chan Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
RNA Therapeutics Institute | Ordförande | - |
Tidigare kända positioner av Phillip Zamore
| Företag | Position | Slut |
|---|---|---|
| ALNYLAM PHARMACEUTICALS, INC. | Grundare | - |
| VOYAGER THERAPEUTICS, INC. | Grundare | - |
Phillip Zamores utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 5 |
|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes therapeutics based on RNA interference | Health Technology |
UMass Chan Medical School
UMass Chan Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Voyager Therapeutics, Inc.
Voyager Therapeutics, Inc. BiotechnologyHealth Technology Develops gene therapies for fatal and debilitating diseases of the central nervous system | Health Technology |
RNA Therapeutics Institute |
















